SPR L6 Ethical Aspects of Clinical Genetics Flashcards
Learning Objectives
- Be able to explain the ‘special nature’ of DNA testing when compared to other medical tests
- Be able to describe the ethical issues involved in the use of predictive or presymptomatic testing for untreatable genetic diseases
- Know why it is important to consider the ethical reasons for testing (or not testing) children for genetic diseases
- Discuss the implications of genetic screening and the potential misuse by insurance companies and employers
- Appreciate the power and also limitations of screening in forensic genetics such as paternity testing
What is genetic information?
- DNA based test
- Detection of product of mutated gene e.g. renal cysts
- Family history e.g. Huntington disease
- Complex family history e.g. heart disease
- Gender may be genetic information
- Age may be genetic information
Define a genetic test?
A test to detect the presence or absence of, or alteration in, a particular gene, chromosome or a gene product, in relation to a genetic disorder.
- Give examples of paternity testing + ethical issues
- What has been a result of this?
- What are the legal implications?
1.
- Filed for maintenance
- Putative father asked for saliva sample
- Sample confirms paternity
- Unlawful DNA theft is an offence (2004)
- Incorporated into 2005 Human Tissue Act
Obtaining and handling personal genetic information
- Give examples of primary general principles
- Give examples of seconary general principles
- What legalities currently cover this?
- Genetic solidarity and altruism, & respect for persons
- – Confidentiality
– Privacy
– Consent
– Non-discrimination
- – Data Protection Act, Human Tissue Act
Testing Children
- What is an important prerequisite?
- When are they usually tested for a late onset disorder?
- What implications can there be?
- What else is important to consider?
- Need to have an effective treatment e.g. childhood cancers (MEN-2, FAP)
- Usually test at ~18 years or over if a ‘late onset disorder’
- Insurance implications
- Does the child want to know (eg. if they have an incurable condition?
Don’t test just because the parents want
- What is MEN-2?
- Outline it’s pathology
- When is diagnosis often made?
- What is curative of this condition?
- Give an example of this case
- Multiple Endocrine Neoplasia type II
- Medullary thyroid cancer
• C-cell hyperplasia
- Often diagnosis in childhood
- Thyroidectomy
- PJM asked to investigate the family and present research findings at the 1988 international MEN meeting in Heidelberg, Germany. Mayo Clinic. Edis discovers the 3 brothers are relatives of the 2 N.Ireland sibs
- PJM asked to find the gene – which we localised to chromosome 10 in 1990 – later exon 10 CysTyr mutation identified in Ret
MEN-2
- Which gene is affected?
- What can the clinical findings be?
- Outline the process of testing in the sisters from the case mentioned before
- later exon 10 CysTyr mutation identified in Ret
- Medullary ca thyroid, Phaeochromocytoma & parathyroid adenoma.
- Tested for Cys to Tyr change at codon 634 in exon 10
- Both gene carriers aged 10 and 8
- No abnormal clinical or lab or screening investigations
- Surgery planned on basis of gene test
- Sister 1 – 9mm focus of MTC
- Sister 2 - 5mm focus of c-cell hyperplasia
- Correct diagnosis and correct to operate
- Established the concept of preventative surgery
Familial Adenomatous Polyposis Coli
- What is it’s incidence?
- What is the mode of inheritance?
- What is it characterised by?
- By age 15, >50% of affected individuals will have multiple polyps, what does this mean about the condition?
- Where do the mutations lie?
- ~1/10,000
- Autosomal Dominant
- Thousands of polyps
- High Penetrance
- Mutations in APC gene (Chromosome 5)
Huntington Disease
- What are the clinical features?
- When is the average onset?
- Chorea
Cognitive dysfunction
Psychiatric illness Relatively selective loss of cells in neurodegeneration
- Average onset early middle life (35 -45 yrs)
Huntington Disease
- What is the mode of inheritance?
- What is the prevalence of this condition?
- What is the underlying genetic cause?
- What is the abnormal range for these repeats?
- What else is clinical significant about the repeats?
- Autosomal Dominant
- 10-12/100,000
- Triplet repeat expansion
CAG(n)- normal up to 35 repeats
1. **\>35 repeats** 2. Greater the expansion, generally worse prognosis and **earlier onset of the disease**
Huntington Disease
- What locus is affected?
- On which gene?
- What is the gene product?
- What is the effect of the mutation?
- What is the treatment?
- What testing is available?
- Locus: 4p16
- Gene IT15
- Gene product: huntingtin
- Effect of mutation: toxic gain of function
- No treatment at present
- Presymptomatic gene testing is available
HD - Genetic Testing
- What will the diagnostic test confirm?
- Outline the Presymptomatic or predictive test
- What should occur before this type of testing?
- confirms diagnosis in symptomatic patient
- testing an at risk asymptomatic person – set protocol for assessing attitudes to, knowledge of, and experience of HD
- At least 2 sessions with a geneticist or genetic counsellor before testing
Pre-implantation diagnosis
- How is this carried out?
- What is needed?
- Why is this carried out?
- What are the drawbacks?
- 8 cell embryo - Remove 1 cell - test DNA for single gene and chromosomal disorders
If abnormal, do not implant egg, If normal then implantation
20-30% “take home baby rate”
1. each disorder needs a licence from the HFEA 2. Parental choice
May avoid termination of pregnancy for serious abnormalities
- Drawbacks – cost, error, stress, travelling
Employment
Outline the issues
- Should employers have the results of genetic tests?
- Should insurers have the results of genetic tests
- Better that employer makes the workplace safe than demanding a genetic test